PMID: 6107587Nov 1, 1980Paper

Intravenous and oral disopyramide after myocardial infarction

Lancet
D P NichollsP C Barnes

Abstract

Patients with acute myocardial infarction admitted to a coronary care unit were given either intravenous and oral disopyramide or matching placebo on admission and throughout their hospital stay. 199 patients entered the trial, and 138 were subsequently shown to have had a myocardial infarct. The placebo and study groups were well matched. There were no significant differences in mortality or observed arrhythmias between the two groups. These results do not confirm earlier observations that prophylaxis with disopyramide reduces mortality after acute myocardial infarction.

Citations

Mar 1, 1994·Clinical Cardiology·J A ReiffelR DiBianco
Sep 22, 1983·The American Journal of Cardiology·R W Campbell
Jan 1, 1985·Molecular Aspects of Medicine·J H BottingM J Walker
Jan 1, 1983·Pharmacology & Therapeutics·D M Roden, R L Woosley
Apr 1, 1992·Journal of the American College of Cardiology·H L GreeneR W Henthorn
Jul 1, 1996·Journal of Cardiovascular Electrophysiology·M S LinkN A Estes
Mar 1, 1987·The American Journal of Medicine·R I Horwitz
Sep 22, 1983·The American Journal of Cardiology·C D Furberg
Jun 1, 1983·Angiology·R R Wilson, A G Wallace

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.